NBP22622801
Novus Biologicals™ Imiquimod, TLR7 ligand
Manufacturer: Novus Biologicals™
Select a Size
| Pack Size | SKU | Availability | Price |
|---|---|---|---|
| Each of 1 | NBP22622801-Each-of-1 | In Stock | ₹ 7,255.49 |
NBP22622801 - Each of 1
In Stock
Quantity
1
Base Price: ₹ 7,255.49
GST (18%): ₹ 1,305.988
Total Price: ₹ 8,561.478
Concentration
2.5 mg/mL
Content And Storage
Store at 4°C short term. Aliquot and store at -20°C long term. Avoid freeze-thaw cycles.
For Use With (Application)
This product is useful for activation of TLR7 and stimulation of TLR7 has been achieved with 5 to 10μL. Use in ligand activation, functional, and in vitro reported in scientific literature (PMID 25957979)
Species
Human/Mouse
Formulation
C14H16N4, HCl
Quantity
0.125 mg
Target
Imiquimod, TLR7 ligand
Related Products
Description
- Imiquimod, TLR7 ligand is an imidazoquinoline amine analog to guanosine
- As a synthetic molecule of the Imidazoquinoline family, it has potent immunostimulatory activity
- Imiquimod has been shown to activate only TLR7
- This activation is MyD88 dependant and leads to the induction of the transcription factor NF-kB
- Buffer: 125μg in 50μL of DMSO (formerly supplied in sterile water) Endotoxin Note: <0.001 EU/μg MW: 276.8